ALK, ROS1, and RET - Does the Partner Gene Matter?

被引：0
|
作者：
Lovly, Christine [1 ]
Childress, Merrida [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
RET; ros1; NTRK1; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MS22.02
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [41] ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
    Yamamoto, Hidetaka
    Yoshida, Akihiko
    Taguchi, Kenichi
    Kohashi, Kenichi
    Hatanaka, Yui
    Yamashita, Atsushi
    Mori, Daisuke
    Oda, Yoshinao
    HISTOPATHOLOGY, 2016, 69 (01) : 72 - 83
  • [42] Detecting NTRK, ROS1, and ALK gene fusions in gastrointestinal tumor patients.
    Potts, Steven James
    Dean, Emma Jane
    Polikoff, Jonathan
    Pacey, Simon
    Chiorean, E. Gabriela
    Chee, Chong Ean
    Sigal, Darren
    Aslam, Maria
    Pauwels, Patrick
    Christiansen, Jason H.
    Multani, Pratik S.
    Lamoureux, Jennifer
    Murphy, Danielle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
    Lee, Seung Eun
    Lee, Boram
    Hong, Mineui
    Song, Ji-Young
    Jung, Kyungsoo
    Lira, Maruja E.
    Mao, Mao
    Han, Joungho
    Kim, Jhingook
    Choi, Yoon-La
    MODERN PATHOLOGY, 2015, 28 (04) : 468 - 479
  • [44] Current landscape and future prospects of RET and ROS1 targets
    Zhang, Hai-Long
    Kong, Qian
    PHARMACEUTICAL PATENT ANALYST, 2023, 12 (03) : 113 - 126
  • [45] Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
    Hubbeling, H. G.
    Choudhury, N.
    Falcon, C.
    Rusch, V. W.
    Park, B.
    Ziv, E.
    Shaverdian, N.
    Gelblum, D.
    Shepherd, A. F.
    Simone, C. B., II
    Wu, A. J.
    Gomez, D. R.
    Drilon, A.
    Rimner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E438 - E439
  • [46] Detection of ALK, RET, ROS1 Rearrangements by NanoString in Brazilian Patients with Non-small Cell Lung Cancer
    Novaes, L.
    de Paula, F.
    Evangelista, A.
    Mattos, L.
    De Marchi, P.
    Silva, C.
    Ferro, L.
    Reis, R. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 986 - 986
  • [47] Frequency of Driver Genes (EGFR, KRAS, BRAF, ALK, RET and ROS1) Alterations in Brazilian Patients with Lung Adenocarcinoma
    Campanha Novaes, L.
    Cavagna, R.
    De Paula, F.
    De Marchi, P.
    Zanon Da Silva, M.
    Evangelista, A.
    Sussuchi Da Silva, L.
    Albino Da Silva, E.
    Leal, L.
    Reis, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S685 - S685
  • [48] Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
    Hubbeling, Harper
    Choudhury, Noura
    Flynn, Jessica
    Zhang, Zhigang
    Falcon, Christina
    Rusch, Valerie W.
    Park, Bernard J.
    Ziv, Etay
    Shaverdian, Narek
    Gelblum, Daphna Y.
    Shepherd, Annemarie F.
    Simone, Charles B., II
    Wu, Abraham J.
    Gomez, Daniel R.
    Drilon, Alexander
    Rimner, Andreas
    JCO PRECISION ONCOLOGY, 2022, 6
  • [49] Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors
    Hornick, Jason L.
    Sholl, Lynette M.
    Dal Cin, Paola
    Childress, Merrida A.
    Lovly, Christine M.
    MODERN PATHOLOGY, 2015, 28 (05) : 732 - 739
  • [50] Expression of ROS1 Predicts ROS1 Gene Rearrangement in Inflammatory Myofibroblastic Tumors
    Hornick, J. L.
    Sholl, L. M.
    Lovly, C. M.
    LABORATORY INVESTIGATION, 2014, 94 : 18A - 18A
12345